Skip to main content
Clinical Trials/NCT02015897
NCT02015897
Completed
Not Applicable

Effect of Physical Therapy on Breast Cancer Related Lymphedema; A Multicenter, Randomized, Single-blind, Equivalence Trial

Esbjerg Hospital - University Hospital of Southern Denmark3 sites in 1 country80 target enrollmentStarted: January 2014Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Esbjerg Hospital - University Hospital of Southern Denmark
Enrollment
80
Locations
3
Primary Endpoint
The percentage volume reduction of lymphoedema (%)

Overview

Brief Summary

The objective of this study is to investigate if Complete Decongestive Therapy is equally effective whether it includes manual lymphatic drainage or not in the treatment of lymphoedema among patients with breast cancer.

Detailed Description

Physical therapy treatment of patients with lymphoedema includes treatment based on the principles of 'Complete Decongestive Therapy' (CDT). CDT consists of following components; skin care, manual lymphatic drainage, bandaging and exercises. Regarding what type of treatment of treatments is most effective, the scientific evidence is sparse. Studies have focused on the time-consuming manual lymphatic drainage, but the scientific evidence is not consistent.

A randomized, single-blind, equivalence trial. A total of 160 breast cancer patients with lymphoedema will be recruited from 3 hospitals and randomised into one of two treatment groups: A: Complete Decongestive TherapyA (incl. manual drainage) or B: Complete Decongestive TherapyB (except manual lymphatic drainage

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • The diagnose breast cancer regardless of date for operation and identified lymphoedema
  • Precede ultrasonic scanning of axilla in order to exclude local relapse
  • Lymphoedema \> 2 cm i.e. stage II-III
  • Completed radiotherapy and/or chemotherapy at least 2 months prior inclusion

Exclusion Criteria

  • Relapse of breast cancer
  • Untreated infection
  • Untreated heart failure
  • Untreated renal failure
  • Untreated deep venous thrombosis in the arm
  • Unable to participate in physiotherapy treatment and/or not able to understand instructions

Outcomes

Primary Outcomes

The percentage volume reduction of lymphoedema (%)

Time Frame: 7 months

Secondary Outcomes

  • Differences in circumference of the arm (composite outcome measure), bodyweight, patient sensation of heaviness, patient sensation of tension, and quality of life(7 months)

Investigators

Sponsor
Esbjerg Hospital - University Hospital of Southern Denmark
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Valgerdur Hilmarsdottir Gram

Associate Professor, PhD

Esbjerg Hospital - University Hospital of Southern Denmark

Study Sites (3)

Loading locations...

Similar Trials